These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 19195736)
1. MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro. Khodadadian M; Leroux ME; Auzenne E; Ghosh SC; Farquhar D; Evans R; Spohn W; Zou Y; Klostergaard J Lung Cancer; 2009 Oct; 66(1):48-57. PubMed ID: 19195736 [TBL] [Abstract][Full Text] [Related]
2. Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells. Wang J; Liu X; Jiang W Chin Med J (Engl); 2000 Oct; 113(10):957-60. PubMed ID: 11775848 [TBL] [Abstract][Full Text] [Related]
3. Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer. Gu T; Ohashi R; Cui R; Tajima K; Yoshioka M; Iwakami S; Sasaki S; Shinohara A; Matsukawa T; Kobayashi J; Inaba Y; Takahashi K Lung Cancer; 2009 Nov; 66(2):176-83. PubMed ID: 19285749 [TBL] [Abstract][Full Text] [Related]
4. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer. Guo L; Zhou Y; Sun Y; Zhang F Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564 [TBL] [Abstract][Full Text] [Related]
5. Reduced expression of Bax in ceramide-resistant HL-60 subline. Sawai H; Kawai S; Domae N Biochem Biophys Res Commun; 2004 Jun; 319(1):46-9. PubMed ID: 15158440 [TBL] [Abstract][Full Text] [Related]
6. Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene. Nagata J; Kijima H; Hatanaka H; Asai S; Miyachi H; Abe Y; Yamazaki H; Nakamura M; Watanabe N; Mine T; Kondo T; Scanlon KJ; Ueyama Y Int J Oncol; 2002 Nov; 21(5):1021-6. PubMed ID: 12370750 [TBL] [Abstract][Full Text] [Related]
7. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Slovak ML; Ho JP; Bhardwaj G; Kurz EU; Deeley RG; Cole SP Cancer Res; 1993 Jul; 53(14):3221-5. PubMed ID: 8391919 [TBL] [Abstract][Full Text] [Related]
8. Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells. Leroux ME; Auzenne E; Evans R; Hail N; Spohn W; Ghosh SC; Farquhar D; McDonnell T; Klostergaard J Prostate; 2007 Nov; 67(15):1699-717. PubMed ID: 17879964 [TBL] [Abstract][Full Text] [Related]
9. [Involvement of bcl-2 in multidrug resistance in human small cell lung cancer cell subline H446/DDP]. Ji FY; Qian GS; Qian P; Chen Y; Guo RL; Li SP; Huang GJ Zhonghua Jie He He Hu Xi Za Zhi; 2006 Mar; 29(3):156-60. PubMed ID: 16677475 [TBL] [Abstract][Full Text] [Related]
10. New advances in the second-line treatment of small cell lung cancer. Hurwitz JL; McCoy F; Scullin P; Fennell DA Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917 [TBL] [Abstract][Full Text] [Related]
12. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein. Doyle LA; Ross DD; Ordonez JV; Yang W; Gao Y; Tong Y; Belani CP; Gutheil JC Br J Cancer; 1995 Sep; 72(3):535-42. PubMed ID: 7669558 [TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Bektas M; Jolly PS; Müller C; Eberle J; Spiegel S; Geilen CC Oncogene; 2005 Jan; 24(1):178-87. PubMed ID: 15637591 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of multidrug resistance of human small cell lung cancer cell line H446/VP. Wang YL; Yan YL; Zhou NJ; Han S; Zhao JX; Cao CL; Lü YH Chin Med J (Engl); 2010 Nov; 123(22):3299-303. PubMed ID: 21163134 [TBL] [Abstract][Full Text] [Related]
15. A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene. Narasaki F; Oka M; Fukuda M; Nakano R; Ikeda K; Takatani H; Terashi K; Soda H; Yano O; Nakamura T; Doyle LA; Tsuruo T; Kohno S Cancer Chemother Pharmacol; 1997; 40(5):425-32. PubMed ID: 9272120 [TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells. Stordal BK; Davey MW; Davey RA Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway. Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778 [TBL] [Abstract][Full Text] [Related]
18. [Expression and reversion of drug resistance- and apoptosis-related genes of a DDP-resistant lung adenocarcinoma cell line A549DDP]. Wang J; Liu X; Wu M Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):422-6. PubMed ID: 11776616 [TBL] [Abstract][Full Text] [Related]
19. Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells. Noguchi M; Kabayama K; Uemura S; Kang BW; Saito M; Igarashi Y; Inokuchi J Glycobiology; 2006 Jul; 16(7):641-50. PubMed ID: 16571667 [TBL] [Abstract][Full Text] [Related]
20. Relationship between chemotherapy response of small cell lung cancer and P-glycoprotein or multidrug resistance-related protein expression. Hsia TC; Lin CC; Wang JJ; Ho ST; Kao A Lung; 2002; 180(3):173-9. PubMed ID: 12177731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]